News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Sleep-Aligned Fasting May Support Overnight Heart Health
July 9, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Researchers found that aligning fasting with the body’s natural sleep cycle before bedtime may support cardiovascular and metabolic health.
Read Article
AMP® BGTC Announces FDA Clearance of Investigational New Drug Application for Gene Therapy Targeting Multiple Sulfatase Deficiency
July 6, 2026 - Grantee/Partner News
- Bespoke Gene Therapy Consortium (BGTC)
The FDA cleared the Investigational New Drug (IND) application for a gene therapy designed to treat children with multiple sulfatase deficiency (MSD), an ultra-rare disease.
Read ArticleNew AI-Driven Tool Could Revolutionize Brain Pressure Monitoring in Intensive Care Patients
September 5, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
EU Roadmap : Key Recommendations, First Roadmap on OoC Devices, Awards to Non-Animal Methods, Artificial Organs Closer to Reality and More
September 4, 2024 - Grantee/Partner News
- Tissue Chip for Drug Screening
Brain Organoids Help Reveal Antiviral Drug’s Promise in Parkinson’s Disease
September 4, 2024 - NCATS News
NCATS scientists used organoids to test the antiviral tilorone as a potential treatment for Parkinson’s disease.
(MABT) and (Accelero) Are Pleased to Announce a Research Collaboration to Identify Novel USP30 Inhibitors
September 4, 2024 - Grantee/Partner News
- Small Business (SBIR)
UAMS Receives $3 Million NIH Grant to Address Feeding Practices at Early Child Care Sites
September 3, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
NCATS-Developed Ketamine Alternative Didn’t Cause Dissociation
September 3, 2024 - NCATS News
- Chemistry Technology
- Our Impact on Drug Discovery and Development
NCATS scientists helped develop a version of ketamine that lacked sedative or dissociative effects in a phase 1 clinical trial.